GlassScriptPhysician profile
Margaret Gray Swain
NPI 1245267178
$2,490.00
in general payments reported to CMS, 2019-2025
30 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $135 · 2021: $226 · 2022: $368 · 2023: $600 · 2024: $514 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $391.45 | 2023-2025 | Veozah |
| Abbvie INC. | $333.86 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $266.84 | 2019-2022 | |
| Organon LLC | $218.42 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $127.91 | 2021-2022 | |
| Evofem Biosciences, INC. | $110.67 | 2021-2024 | Phexxi |
| Agile Therapeutics, INC. | $105.10 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $99.36 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $97.66 | 2023 | Myfembree |
| Exeltis, USA INC. | $93.91 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $83.88 | 2022-2025 | Fluent Fluid Management System, Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $71.09 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.11 | 2019-2024 | |
| Meditrina | $63.95 | 2022-2023 | |
| Therapeuticsmd, INC. | $46.02 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $45.83 | 2019 | |
| Daiichi Sankyo INC. | $32.61 | 2019-2021 | |
| Pfizer INC. | $29.54 | 2024 | |
| Coopersurgical, INC. | $29.02 | 2019-2025 | Endosee |
| Dexcom, INC. | $19.10 | 2024 | Dexcom G6 Transmitter |
| Impel Pharmaceuticals INC. | $18.27 | 2022 | |
| Allergan, INC. | $17.43 | 2019 | |
| Medtronic, INC. | $16.86 | 2023 | V-Loc 180 |
| Sage Therapeutics, LLC | $16.19 | 2025 | Zurzuvae |
| Abbott Laboratories | $15.39 | 2023 | Proclaim |
| Novo Nordisk INC | $15.32 | 2024 | Wegovy |
| Amag Pharmaceuticals, INC. | $15.22 | 2019 | |
| Molnlycke Health Care US, LLC | $14.77 | 2024 | Avance, Mepilex Border Post-Op |
| Avion Pharmaceuticals | $12.67 | 2022 | |
| Lupin INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Gray Swain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.